Red-yellow Papules and Nodules All over the Body: A Quiz
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0562Keywords:
histopathology, non-Langerhans cell histiocytosis, non-langerhans cell histiocytosesDownloads
References
Durrington P. Dyslipidaemia. Lancet 2003; 362: 717–731. DOI: https://doi.org/10.1016/S0140-6736(03)14234-1
Janku F, Diamond EL, Goodman AM, Raghavan VK, Barnes TG, Kato S, et al. Molecular profiling of tumor tissue and plasma cell-free DNA from patients with non-langerhans cell histiocytosis. Mol Cancer Ther 2019; 18: 1149–1157. DOI: https://doi.org/10.1158/1535-7163.MCT-18-1244
Roskoski R Jr. Properties of FDA-approved small molecule protein kinase inhibitors: a 2020 update. Pharmacol Res 2020; 152: 104609. DOI: https://doi.org/10.1016/j.phrs.2019.104609
Collie JS, Harper CD, Fillman EP. Juvenile Xanthogranuloma. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2025.
Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 2003; 27: 579–593. DOI: https://doi.org/10.1097/00000478-200305000-00003
Mija LA, Zhu CK, Mukovozov I. A systematic review of clinical features and treatment outcomes of xanthoma disseminatum. J Cutan Med Surg 2024; 28: 572–576. DOI: https://doi.org/10.1177/12034754241274356
Zak A, Zeman M, Slaby A, Vecka M. Xanthomas: clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2014; 158: 181–188. DOI: https://doi.org/10.5507/bp.2014.016
Luz FB, GasparTAP, Kalil-Gaspar N, Ramos-e-Silva M. Multicentric reticulohistiocytosis. J Eur Acad Dermatol Venereol 2001; 15: 524–531. DOI: https://doi.org/10.1046/j.1468-3083.2001.00362.x
Durham BH, Lopez Rodrigo E, Picarsic J, Abramson D, Rotemberg V, De Munck S, et al. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat Med 2019; 25: 1839–1842. DOI: https://doi.org/10.1038/s41591-019-0653-6
Aaroe A, Kurzrock R, Goyal G, Goodman AM, Patel H, Ruan G, et al. Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. Blood Adv 2023; 7: 3984–3992. DOI: https://doi.org/10.1182/bloodadvances.2022009013
Published
How to Cite
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.